Background For psychotic disorders (ie schizophrenia), pharmacotherapy plays a key role in
controlling acute and long-term symptoms. To find the optimal individual dose and dosage …

Variability in hepatic cytochrome P450 (CYP) enzymes such as 2C19 and 2D6 may
influence side-effect and efficacy outcomes for antipsychotics. Aripiprazole and risperidone …

Second-generation antipsychotic metabolism is mainly carried out by the CYP450
superfamily, which is highly polymorphic. Therefore, knowing the influence of the different …

Introduction Aripiprazole and olanzapine are atypical antipsychotics. Both drugs can induce
metabolic changes; however, the metabolic side effects produced by aripiprazole are more …

The concurrent use of several medications is a common practice in the treatment of complex
psychiatric conditions. One such commonly used combination is aripiprazole (ARI), an …

Autism spectrum disorder (ASD) may affect family and social life profoundly. Although there
is no selective pharmacotherapy for ASD, the Food and Drug Administration (FDA) has …

We investigated the association between genetic variations in pharmacodynamic genes and
risperidone-induced increased prolactin levels in children and adolescents with autism …

Background Poor metabolizer Administer no more than 10 mg/day or 300 mg/month (67–
75% of the standard maximum dose of aripiprazole) 1 The risk of side effects is increased …

Aripiprazole is an atypical antipsychotic used for the treatment of schizophrenia and bipolar
disorder. It is a secondgeneration (atypical) antipsychotic, frequently referred to as third …

Background: Schizophrenia, which affects about 0.85% of people worldwide, is the most
common illness among psychotic disorders. Antipsychotic drugs have been a mainstay of …